Health Care/Hospital

Virtual pitching competition with 20 Swiss startups puts innovation center stage

SHANGHAI, May 14, 2020 /PRNewswire/ -- Following Switzerland's record-performance at CESASIA 2019 winning 6 CES Innovation Awards, SwissTech will be taking the stage again inAsia this 10 June – virtually! SwissTech Pitchinar 2020 is to be joined by 20 leading Swiss startups in the fields of Heal...

2020-05-14 13:18 4071

Orbitkey is Here to Lend a Helping Hand

MELBOURNE, Australia, May 14, 2020 /PRNewswire/ -- As a response to the COVID-19 pandemic,Melbourne-based organisation brand Orbitkey has utilised their product design expertise to create a Sanitiser Holder. They are giving away 500 units to those on the front line, and donating 100% of profits t...

2020-05-14 12:32 2964

MetroResidences Unveils Safe Home Programme to Facilitate Alternative Accommodations for Frontline Workers

SINGAPORE, May 14, 2020 /PRNewswire/ -- MetroResidences, a leading Tech-driven hospitality company has announced the launch of Safe Home Programme in Singapore and Japan. The initiative aims to support not only healthcare workers but also other...

2020-05-14 12:27 5479

Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)

FORT LAUDERDALE, Florida, May 14, 2020 /PRNewswire/ -- Veloce BioPharma LLC reports today that their Halodine® Antiseptics have demonstrated rapid viricidal efficacy against SARS-CoV-2, the virus that causes COVID-19. Halodine® is a proprietary povidone-iodine antiseptic developed in partnership ...

2020-05-14 09:26 3084

Philippine Red Cross launches RC143 contact tracing app with data-free usage for Smart mobile subscribers

MANILA, Philippines, May 14, 2020 /PRNewswire/ -- The Philippine Red Cross (PRC) has launched a new mobile application called RC143 which is designed to help health authorities in contact tracing of COVID-19 cases. Smart is enabling its subscribers to download and use the mobile app free of data ...

2020-05-14 08:00 14336

Venture Capitalists and Industry Leaders Unite to Support Startup Community in First-Of-Kind Mentoring and Charity Fundraising Campaign

SINGAPORE, May 14, 2020 /PRNewswire/ -- More than 140 Venture firms, accelerators, incubators and other members of the startup community inSoutheast Asia are coming out strongly to support a community-led charity fundraising campaign aiming to raise the equivalent of 50,000 meals for those in nee...

2020-05-14 08:00 4113

TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

SUZHOU, China, May 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today jointl...

2020-05-14 07:30 8252

Hanwha Helps the Fight Against COVID-19 by Providing Life Park, a Smart Training Institute in the City of Yongin, Gyeonggi Province in Korea, as a Treatment Center

SEOUL, South Korea, May 14, 2020 /PRNewswire/ -- Hanwha is closely monitoring the COVID-19 global health crisis and implementing various measures to protect the health and safety of their employees and slow the spread of coronavirus by helping hard-hit communities.

2020-05-14 07:00 2355

VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting

AUSTIN, Texas, May 13, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), an epigenetics company developing simple, easy to use and cost effective blood tests to help diagnose a range of cancers, will present three abstracts at the 2020 ASCO Annual Meeting. The first abs...

2020-05-14 06:54 7907

Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020

- Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, biomarker and HRQoL analyses for tepotinib†, the first MET inhibitor to have received a regulatory approval for NSCLC withMET gene alterations - Two-year follow-up for first-in-class bifunctional im...

2020-05-14 06:46 2341

Frost & Sullivan Assesses the Top 21 Global Risks that Threaten the Next Decade

Inability to mitigate global risks such as rise of infectious diseases like COVID-19 can adversely impact businesses, societies, and economies SANTA CLARA, California, May 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Global Future Risks—Future-proofing Your Strategies, 2030, provi...

2020-05-14 03:44 1784

Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19

HYDERABAD, India, May 14, 2020 /PRNewswire/ -- Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distributio...

2020-05-14 01:56 3093

Telehealth to Experience Massive Growth with COVID-19 Pandemic, Says Frost & Sullivan

Demand for telehealth will soar by 64.3% in the US in 2020 as the COVID-19 pandemic disrupts the practice of medicine and the delivery of healthcare SANTA CLARA, California, May 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Telehealth—A Technology-Based Weapon in the War Against the...

2020-05-14 01:05 2775

Trip.com Group joins WTTC in launching Safe Travels protocol

SHANGHAI, May 14, 2020 /PRNewswire/ -- Leading international online travel services provider (OTA) Trip.com Group today announced its role in overseeing the implementation of an industry initiative led by the World Travel and Tourism Council (WTTC), set to lend impetus to the revival of the secto...

2020-05-14 01:03 2728

Dreamwood(TM) Offers Olfactive Warmth, Cosmetic Benefits and Positive Impact

GENEVA, May 13, 2020 /PRNewswire/ -- Firmenich, the world's largest privately-owned perfume and taste company, is proud to launch its newest exclusive, captive ingredient Dreamwood™. Inspired by the iconic Mysore sandalwood, Dreamwood™ offers the signature mystical, creamy olfactive warmth with ...

2020-05-13 21:53 2157

DERMALOG Fever Detection Protects Draegerwerk AG Production

- Despite Covid-19, assembly lines in many factories do not stop. Production at Draeger is also in full operation. As a manufacturer of ventilators, the German company's products are currently in high demand. To keep the risk of infection among employees as low as possible, Draeaeger has implemen...

2020-05-13 21:10 1457

Havas Health & You Launches Havas Mango

NEW YORK, May 13, 2020 /PRNewswire/ -- In 2019, wellness was one of the fastest growing consumer priorities in the world. In 2020, as we face a new health reality globally, this priority has become critical, as consumers are thinking more about personal and collective wellbeing than perhaps ever ...

2020-05-13 21:10 1055

AIA Brings Its Global Ambassador, David Beckham, and Partner, Tottenham Hotspur, Together to Promote Healthier, Longer, Better Lives

SINGAPORE, May 13, 2020 /PRNewswire/ -- AIA, the largest independent publicly listed pan-Asian life insurance group, today launched a new content series (filming was conducted prior to theCOVID-19 pandemic) in partnership with its Global AmbassadorDavid Beckham and partner Tottenham Hotspur Footb...

2020-05-13 20:43 1569

Happiness Biotech Announced Innovative Cultivation Technology of Lucidum

NANPING, China, May 13, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has successfully developed an innovative cultivation technology of lucidum, which...

2020-05-13 20:00 4445

First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors

SHANGHAI and ROCKVILLE, Md., May 13, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, today announ...

2020-05-13 20:00 5143
1 ... 683684685686687688689 ... 808